Serum 3-Hydroxybutyrate is Expected to Serve as One of the Supportive Diagnostic Markers of Persistent Idiopathic Dentoalveolar Pain (PDAP)

References

• Orofacial T. International classification of orofacial pain, 1st edition (ICOP). Cephalalgia. 2020;40(2):129–221. doi:10.1177/0333102419893823
   PubMed Web of Science ®Google Scholar
• Woda A, Tubert-Jeannin S, Bouhassira D, et al. Toward a new taxonomy of idiopathic orofacial pain. Pain. 2005;116:396–406. doi:10.1016/j.pain.2005.05.009
   PubMed Web of Science ®Google Scholar
• Melis M, Lobo SL, Ceneviz C, et al. Atypical odontalgia: a review of the literature. Headache. 2003;43:1060–1074. doi:10.1046/j.1526-4610.2003.03207.x
   PubMed Web of Science ®Google Scholar
• Baad-Hansen L. Atypical odontalgia–pathophysiology and clinical management. J Oral Rehabil. 2008;35:1–11. doi:10.1111/j.1365-2842.2007.01813.x
   PubMed Web of Science ®Google Scholar
• Benjamin P. Pain after routine endodontic therapy may not have originated from the treated tooth. J Am Dent Assoc. 2011;142:1383–1384. doi:10.14219/jada.archive.2011.0140
   PubMed Web of Science ®Google Scholar
• Ram S, Teruel A, Kumar SK, et al. Clinical characteristics and diagnosis of atypical odontalgia: implications for dentists. J Am Dent Assoc. 2009;140:223–228. doi:10.14219/jada.archive.2009.0136
   PubMed Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache Society (IHS). The international classification of headache disorders. 3rd ed. Cephalalgia. 2013;33:629–808. doi:10.1177/0333102413485658
   PubMed Web of Science ®Google Scholar
• Benoliel R. Atypical odontalgia: quo vadis? Quintessence Int. 2013;44(6):383. doi:10.3290/j.qi.a29632
   PubMed Web of Science ®Google Scholar
• Ahlawat J, Malhotra A, Sharma A, Talwar S. Atypical odontalgia: a non-odontogenic toothache of neuropathic origin. Int J Res Ayurveda Pharm. 2016;7:98–101. doi:10.7897/2277-4343.07137
   Google Scholar
• List T, Leijon G, Helkimo M, et al. Clinical findings and psychosocial factors in patients with atypical odontalgia: a case-control study. J Orofac Pain. 2007;21:89–98.
   PubMed Web of Science ®Google Scholar
• Kaddurah-Daouk R, Krishnan KR. Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology. 2009;34:173–186. doi:10.1038/npp.2008.174
   PubMed Web of Science ®Google Scholar
• Setoyama D, Kato TA, Hashimoto R, et al. Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-a multicenter pilot analysis. PLoS One. 2016;11:e0165267.
   PubMed Web of Science ®Google Scholar
• Sada N, Lee S, Katsu T, Otsuki T, Inoue T. Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy. Science. 2015;347:1362–1367. doi:10.1126/science.aaa1299
   PubMed Web of Science ®Google Scholar
• Youm YH, Nguyen KY, Grant RW, et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21:263–269. doi:10.1038/nm.3804
   PubMed Web of Science ®Google Scholar
• Saito N, Itoga M, Minakawa S, Kayaba H. Serum 3-hydroxybutyrate in patients with psychogenic somatoform symptoms may be a predictor of the effectiveness of sertraline and venlafaxine. Int J Gen Med. 2021;14:1785–1795. doi:10.2147/IJGM.S300517
   PubMed Web of Science ®Google Scholar
• Okun A, Stein RE, Bauman LJ, Silver EJ. Content validity of the psychiatric symptom index, CES-depression scale, and state-trait anxiety inventory from the perspective of DSM-IV. Psychol Rep. 1996;79:1059–1069. doi:10.2466/pr0.1996.79.3.1059
   PubMed Web of Science ®Google Scholar
• Weissman MM, Sholomskas D, Pottenger M, Prusoff BZ, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol. 1977;106:203–214. doi:10.1093/oxfordjournals.aje.a112455
   PubMed Web of Science ®Google Scholar
• Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety. Palo Alto, CA: Consulting Psychologist Press; 1970.
   Google Scholar
• Nakazato K, Mizuguchi K. Studies on psychometric characteristics of depression in the field of internal medicine. Shinshin-Igaku. 1982;22:107–112.
   Google Scholar
• 3-Hydroxybutyrate REAGENT KIT. KAINOS Co., Ltd. Tokyo, Japan. Available from: http://www.kainos.co.jp/jp/products/pdf/TKA5520.pdf. Accessed April 23, 2021.
   Google Scholar
• Bates RE Jr, Stewart CM. Atypical odontalgia: phantom tooth pain. Oral Surg Oral Med Oral Pathol. 1991;72:479–483. doi:10.1016/0030-4220(91)90564-S
   PubMedGoogle Scholar
• Jacobs R, Wu CH, Goossens K, et al. A case-control study on the psychophysical and psychological characteristics of the phantom tooth phenomenon. Clin Oral Investig. 2002;6:58–64. doi:10.1007/s00784-001-0149-9
   PubMedGoogle Scholar
• Rees RT, Harris M. Atypical odontalgia. Br J Oral Surg. 1979;16:212–218. doi:10.1016/0007-117X(79)90027-1
   PubMedGoogle Scholar
• Reik L Jr. Atypical odontalgia: a localized form of atypical facial pain. Headache. 1984;24:222–224. doi:10.1111/j.1526-4610.1984.hed2404222.x
   PubMed Web of Science ®Google Scholar
• Schnurr RF, Brooke R. Atypical odontalgia: update and comment on long-term follow-up. Oral Surg Oral Med Oral Pathol. 1992;73:445–448. doi:10.1016/0030-4220(92)90322-H
   PubMedGoogle Scholar
• Abiko Y, Matsuoka H, Chiba I, Toyofuku A. Current evidence on atypical odontalgia: diagnosis and clinical management. Int J Dent. 2012;2012:518548. doi:10.1155/2012/518548
   PubMedGoogle Scholar
• Baad-Hansen L, Leijon G, Svensson P, List T. Comparison of clinical findings and psychosocial factors in patients with atypical odontalgia and temporomandibular disorders. J Orofac Pain. 2008;22:7–14.
   PubMed Web of Science ®Google Scholar
• Woda A, Pionchon P. A unified concept of idiopathic orofacial pain: pathophysiologic features. J Orofac Pain. 1999;13:172–184.
   PubMedGoogle Scholar
• Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome and other oral sensory disorders: a unifying hypothesis. Pain Res Manag. 2003;8:133–135. doi:10.1155/2003/654735
   PubMedGoogle Scholar
• Ditre JW, Brandon TH, Zale EL, Meagher MM. Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychol Bull. 2011;137:1065–1093. doi:10.1037/a0025544
   PubMed Web of Science ®Google Scholar
• Unell L, Söderfeldt B, Halling A, Birkhed D. Explanatory models for clinically determined and symptom-reported caries indicators in an adult population. Acta Odontol Scand. 1999;57:132–138. doi:10.1080/000163599428850
   PubMed Web of Science ®Google Scholar
• Al-Wahadni A, Linden GJ. Dentine hypersensitivity in Jordanian dental attenders. A case control study. J Clin Periodontol. 2002;29:688–693. doi:10.1034/j.1600-051X.2002.290804.x
   PubMed Web of Science ®Google Scholar
• Fluharty M, Taylor AE, Grabski M, Munafò MR. The association of cigarette smoking with depression and anxiety: a systematic review. Nicotine Tob Res. 2017;19:3–13. doi:10.1093/ntr/ntw140
   PubMed Web of Science ®Google Scholar
• Brooke RI, Schnurr RF. Diagnosing and treating atypical odontalgia. J Mass Dent Soc. 1995;44:30–32.
   PubMedGoogle Scholar
• Arora S, Henderson SO, Long T, Menchine M. Diagnostic accuracy of point of care testing for diabetic ketoacidosis at emergency department triage: beta hydroxybutyrate versus the urine dipstick. Diabetes Care. 2011;34:852–854. doi:10.2337/dc10-1844
   PubMed Web of Science ®Google Scholar
• Noyes KJ, Crofton P, Bath LE, et al. Hydroxybutyrate near patient testing to evaluate a new end point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diabetes. 2007;8:150–156. doi:10.1111/j.1399-5448.2007.00240.x
   PubMed Web of Science ®Google Scholar
• Laffel LM, Wentzell K, Loughlin C, et al. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial. Diabet Med. 2006;23:278–284. doi:10.1111/j.1464-5491.2005.01771.x
   PubMed Web of Science ®Google Scholar
• Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. 2014;25:42–52. doi:10.1016/j.tem.2013.09.002
   PubMed Web of Science ®Google Scholar
• Cotter DG, Schugar RC, Crawford PA. Ketone body metabolism and cardiovascular disease. Am J Physiol Heart Circ Physiol. 2013;304:H1060–H1076. doi:10.1152/ajpheart.00646.2012
   PubMed Web of Science ®Google Scholar
• Chen L, Miao Z, Xu X. Beta-hydroxybutyrate alleviates depressive behaviors in mice possibly by increasing the histone3-lysine9-beta- hydroxybutyrylation. Biochem Biophys Res Commun. 2017;490:117–122. doi:10.1016/j.bbrc.2017.05.184
   PubMed Web of Science ®Google Scholar
• Yamanashi T, Iwata M, Kamiya N, et al. Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses. Sci Rep. 2017;7:7677. doi:10.1038/s41598-017-08055-1
   PubMed Web of Science ®Google Scholar
• Minervini G, Franco R, Maddalena M, et al. Correlation between Temporomandibular Disorders (TMD) and Posture Evaluated trough the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD): a systematic review with meta-analysis. J Clin Med. 2023;12:2652. doi:10.3390/jcm12072652
   PubMed Web of Science ®Google Scholar
• Minervini G, Franco R, Maddalena M, et al. Prevalence of temporomandibular disorders in subjects affected by Parkinson disease: a systematic review and metanalysis. J Oral Rehabil. 2023;50:877–885. doi:10.1111/joor.13496
   PubMed Web of Science ®Google Scholar
• Ito M, Kimura H, Yoshida K, et al. Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region. Clin Neuropharmacol. 2010;33:79–83. doi:10.1097/WNF.0b013e3181cb5793
   PubMed Web of Science ®Google Scholar